D.J. Heal

707 total citations
19 papers, 588 citations indexed

About

D.J. Heal is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, D.J. Heal has authored 19 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 7 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in D.J. Heal's work include Neurotransmitter Receptor Influence on Behavior (10 papers), Neuroscience and Neuropharmacology Research (5 papers) and Pharmacology and Obesity Treatment (4 papers). D.J. Heal is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (10 papers), Neuroscience and Neuropharmacology Research (5 papers) and Pharmacology and Obesity Treatment (4 papers). D.J. Heal collaborates with scholars based in United Kingdom and United States. D.J. Heal's co-authors include Keith F. Martin, Chrisana Gundlah, Sidney B. Auerbach, Helen C. Jackson, Sue Aspley, Sharon C. Cheetham, M.R. Prow, W. R. Buckett, Ian Phillips and Christine Kettle and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

D.J. Heal

17 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.J. Heal United Kingdom	8	283	249	144	124	115	19	588
Graham P. Luscombe United Kingdom	11	256 0.9×	236 0.9×	46 0.3×	79 0.6×	109 0.9×	19	516
M.R. Prow United Kingdom	8	138 0.5×	195 0.8×	56 0.4×	74 0.6×	91 0.8×	10	361
Shan Xie United States	17	474 1.7×	415 1.7×	67 0.5×	85 0.7×	184 1.6×	26	984
Aaron N.A. Verty Australia	16	552 2.0×	308 1.2×	332 2.3×	295 2.4×	66 0.6×	19	905
Kazuyoshi Horisaka Japan	14	88 0.3×	269 1.1×	107 0.7×	176 1.4×	147 1.3×	63	632
S P Vickers United Kingdom	10	298 1.1×	390 1.6×	343 2.4×	268 2.2×	235 2.0×	15	987
Giorgio Marchese Italy	15	258 0.9×	339 1.4×	58 0.4×	83 0.7×	177 1.5×	43	742
Ildikó Rácz Germany	12	284 1.0×	389 1.6×	61 0.4×	179 1.4×	306 2.7×	21	968
Silvana Gaetani Italy	12	370 1.3×	277 1.1×	61 0.4×	141 1.1×	104 0.9×	13	682
Víctor Echeverry‐Alzate Spain	17	263 0.9×	247 1.0×	30 0.2×	107 0.9×	194 1.7×	34	710

Countries citing papers authored by D.J. Heal

Since Specialization

Citations

This map shows the geographic impact of D.J. Heal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.J. Heal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.J. Heal more than expected).

Fields of papers citing papers by D.J. Heal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.J. Heal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.J. Heal. The network helps show where D.J. Heal may publish in the future.

Co-authorship network of co-authors of D.J. Heal

This figure shows the co-authorship network connecting the top 25 collaborators of D.J. Heal. A scholar is included among the top collaborators of D.J. Heal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.J. Heal. D.J. Heal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Heal, D.J., S P Vickers, David P. Hackett, & Peter H. Hutson. (2013). P.1.g.032 Metabolic effects of lisdexamfetamine in a rat model of human obesity with insulin resistance. European Neuropsychopharmacology. 23. S207–S207. 4 indexed citations

Hofmann, Susanna M., M. Tschöp, Jochen Antel, et al.. (2005). Neuroendocrine modulators of energy balance: perspectives for obesity research.. UCL Discovery (University College London). 161–172. 1 indexed citations

Arch, J R, Jochen Antel, Nick Finer, D.J. Heal, & Gary S. Krause. (2005). Thermogenesis and related metabolic targets for anti-obesity drugs. UCL Discovery (University College London). 2003. 143–160. 1 indexed citations

Smith, Sharon L., Kevin S. J. Thompson, Bruce J. Sargent, & D.J. Heal. (2001). BTS 72664 – A Novel CNS Drug With Potential Anticonvulsant, Neuroprotective, and Antimigraine Properties. CNS Drug Reviews. 7(2). 146–171. 9 indexed citations

Kettle, Christine, Sharon C. Cheetham, Keith F. Martin, M.R. Prow, & D.J. Heal. (1999). The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex. Neuropharmacology. 38(9). 1421–1430. 15 indexed citations

Heal, D.J., Sharon C. Cheetham, M.R. Prow, Keith F. Martin, & W. R. Buckett. (1998). A comparison of the effects on central 5‐HT function of sibutramine hydrochloride and other weight‐modifying agents. British Journal of Pharmacology. 125(2). 301–308. 87 indexed citations

Gosden, Jane & D.J. Heal. (1998). Evaluation of sibutramine, its active metabolites and dexfenfluramine in the MDMA-cued drug discrimination test. 3. 122. 2 indexed citations

Rowley, Helen L., et al.. (1998). Zotepine elevates dopamine in the frontal cortex of freely-moving rats measured by [n vivo microdialysis. European Neuropsychopharmacology. 8. S241–S241. 1 indexed citations

Heal, D.J., et al.. (1998). Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine.. PubMed. 22 Suppl 1. S18–28; discussion S29. 133 indexed citations

10.

Jackson, Helen C., et al.. (1997). Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. British Journal of Pharmacology. 121(8). 1758–1762. 116 indexed citations

11.

Aspley, Sue, Susan Butler, M.R. Prow, Keith F. Martin, & D.J. Heal. (1997). D-fenfluramine-induced depletion of rat brain 5-HT is prevented by sibutramine or fluoxetine pretreatment. 1. 374. 1 indexed citations

12.

Gundlah, Chrisana, Keith F. Martin, D.J. Heal, & Sidney B. Auerbach. (1997). In Vivo Criteria To Differentiate Monoamine Reuptake Inhibitors from Releasing Agents: Sibutramine Is a Reuptake Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 283(2). 581–591. 100 indexed citations

13.

Heal, D.J., et al.. (1996). Norzotepine: Atypical antipsychotic profile of zotepine's major active metabolite. Schizophrenia Research. 18(2-3). 147–147. 2 indexed citations

14.

Atkinson, Jeffrey, et al.. (1996). Binding of zotepine to serotonin (5-HT) receptor subtypes. Schizophrenia Research. 18(2-3). 141–142. 2 indexed citations

15.

Heal, D.J., et al.. (1996). BTS 73 947, a novel D1/D5 antagonist with predicted atypical antipsychotic activity. European Neuropsychopharmacology. 6. 105–105. 1 indexed citations

16.

Heal, D.J., et al.. (1995). P-4-15 Zotepine: Preclinical tests predict antipsychotic efficacy and an atypical profile. European Neuropsychopharmacology. 5(3). 331–332. 2 indexed citations

17.

Heal, D.J., Carole Czudek, & W. R. Buckett. (1994). Common profile of D1 receptor antagonists and atypical antipstchotic drugs revealed by analysis of dopamine turnover. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 18(4). 803–821. 8 indexed citations

18.

Martin, Keith F., et al.. (1992). Characterization of 8‐OH‐DPAT‐induced hypothermia in mice as a 5‐HT_1A autoreceptor response and its evaluation as a model to selectively identify antidepressants. British Journal of Pharmacology. 107(1). 15–21. 102 indexed citations

19.

Cheetham, Sharon C., et al.. (1990). The inhibition constants for blockade of [3H]5-hydroxytryptamine reuptake are variable and dependent on a tissue concentration. European Journal of Pharmacology. 183(5). 1901–1902. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact